Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Govindasamy Mugesh

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 8, 2019
Modeling Thioredoxin Reductase-Like Activity with Cyclic Selenenyl Sulfides: Participation of an NH⋅⋅⋅Se Hydrogen Bond through Stabilization of the Mixed Se-S IntermediateKenta Arai, Takahiko Matsunaga, Haruhito Ueno, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 22, 2025
Quercetin inhibits platelet activation and ER-stress mediated autophagy in response to extracellular histoneKurnegala Manikanta, Somanathapura K NaveenKumar, Mahadevappa Hemshekhar, et al.
EMBO Molecular Medicine|April 1, 2021
Antioxidant nanozyme counteracts HIV-1 by modulating intracellular redox potentialShalini Singh, Sourav Ghosh, Virender Kumar Pal, et al.
Molecular Metabolism|August 1, 2025
DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolismDotan Moskovich, Daniel Beilinson, Amit Rosemarin, et al.
Plos One|July 23, 2013
The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout miceSih Min Tan, Arpeeta Sharma, Derek Y C Yuen, et al.
The FEBS Journal|August 4, 2011
Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captoprilMohd Akif, Geoffrey Masuyer, Sylva L U Schwager, et al.
Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 8, 2019
Modeling Thioredoxin Reductase-Like Activity with Cyclic Selenenyl Sulfides: Participation of an NH⋅⋅⋅Se Hydrogen Bond through Stabilization of the Mixed Se-S IntermediateKenta Arai, Takahiko Matsunaga, Haruhito Ueno, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 22, 2025
Quercetin inhibits platelet activation and ER-stress mediated autophagy in response to extracellular histoneKurnegala Manikanta, Somanathapura K NaveenKumar, Mahadevappa Hemshekhar, et al.
EMBO Molecular Medicine|April 1, 2021
Antioxidant nanozyme counteracts HIV-1 by modulating intracellular redox potentialShalini Singh, Sourav Ghosh, Virender Kumar Pal, et al.
Molecular Metabolism|August 1, 2025
DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolismDotan Moskovich, Daniel Beilinson, Amit Rosemarin, et al.
Plos One|July 23, 2013
The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout miceSih Min Tan, Arpeeta Sharma, Derek Y C Yuen, et al.
The FEBS Journal|August 4, 2011
Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captoprilMohd Akif, Geoffrey Masuyer, Sylva L U Schwager, et al.
Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Pageof 11